Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ozanimod de-escalation in stable MS patients
NCT06529406Phase 4Recruiting
- Sponsor
- University of Colorado Denver
- Start
- Jul 2024
- Primary completion
- Aug 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ozanimod in multiple sclerosis (MS), sponsored by University of Colorado Denver. Started Jul 2024; status: recruiting.
02
Drugs
ozanimod
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT06529406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06529406.